Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
Summary
- Conditions
- Hypertension
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 20 years and 79 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01518855
- Collaborators
- Not Provided
- Investigators
- Study Director: Bayer Study Director Bayer
Get Well Soon